Physician profile
Gary D Lichten
NPI 1174517932
$2,301.82
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,892 · 2020: $379 · 2021: $30.91.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $570.12 | 2019-2020 | |
| Genzyme Corporation | $279.56 | 2019 | |
| Lilly USA, LLC | $244.92 | 2019 | |
| Janssen Scientific Affairs, LLC | $200.61 | 2019-2020 | |
| Galderma Laboratories, L.P. | $179.77 | 2019 | |
| Janssen Biotech, INC. | $153.09 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $147.64 | 2019-2020 | |
| Pfizer INC. | $137.66 | 2019-2020 | |
| Merz North America, INC. | $66.24 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $58.38 | 2019 | |
| Prugen, INC. Pharmaceuticals | $51.68 | 2019-2020 | |
| Leo Pharma INC. | $33.66 | 2019 | |
| Sun Pharmaceutical Industries INC. | $31.46 | 2019 | |
| Epi Health, LLC | $29.32 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $22.05 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.67 | 2020 | |
| Celgene Corporation | $17.42 | 2019 | |
| Biofrontera INC. | $16.79 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.36 | 2019 | |
| Almirall LLC | $13.36 | 2019 | |
| Encore Dermatology INC. | $11.06 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Lichten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.